News

Our Healthcare News

Revance’s RT002 Meets Primary and Secondary Endpoints, Achieves 6-Month Duration in Phase 3 Trials

NEWARK, Calif.—(BUSINESS WIRE)—Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, today announced its next-generation neuromodulator…  

Dec 05 2017

Otsuka and Proteus Announce First U.S. FDA Approval of a Digital Medicine System:  ABILIFY MYCITE

TOKY, Japan and REDWOOD CITY, California– Otsuka Pharmaceutical Co., Ltd.  (Otsuka) and Proteus Digital Health (Proteus) today announce that the United States Food and Drug…  

Nov 14 2017

Bill Burns Nominated for Election to Molecular Partners’ Board of Directors

Zurich-Schlieren, SWITZERLAND—Molecular Partners AG (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies*, today announced that its Board…  

Oct 03 2017

Revance Appoints Mark Foley to its Board of Directors

NEWARK, California—Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions, today announced that Mark Foley…  

Sep 06 2017

IntegenX Applauds the Passage of the Rapid DNA Act of 2017

Pleasanton, California – – IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The…  

Aug 17 2017

Centers for Medicare/Medicaid Services Establishes Coding and Payment for Eustachian Tube Balloon

PLYMOUTH, Minnesota—Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive…  

May 22 2017

Revance Announces Positive Results in RT002 Injectable Phase 2 Cervical Dystonia Trial

NEWARK, Calif.——Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions, today announced duration of effect…  

May 18 2017

Health Care Innovations are Coming to Your Digital Device

The Wall Street Journal - Opinion/Commentary

By Regina Benjamin and Adnrew Theompson

Mobile phones and tablets have pushed themselves to the center of modern life.…  

Feb 20 2017

Entellus Medical Announces Presentation of Positive Clinical Results in Pediatric Patients

PLYMOUTH, MN and CHICAGO, IL—Entellus Medical, Inc. (NASDAQ: ENTL) announced today that Dr. Zachary M. Soler, MD, MSc, Medical University of South Carolina, presented the…  

May 19 2016